| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| SFBC International, Inc. |
| 11190 Biscayne Blvd., N. Miami, FL 33181 * (305) 895-0304 |
| Business Description | The company is a contract research organization which conducts clinical research and provides drug development services for clients in the pharmaceutical and biotechnology industries. |
|
Filing Information Not yet | |||
| To Trade As | SFBX (NASNTL) | Industry | Service (SIC 8731) |
| Type of Stock Offered | Common Shares | Filing Date | 8/17/99 |
| Domestic Shares Filed | 12,500,000 | Filing Price | $8.00 |
| Foreign Shares Filed | 0 | Offering Amount | $100,000,000 |
| Company Shares | 12,500,000 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| H.D. Brous & Co., Inc. | Lead Manager | (800) 382-7170 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/97 | 12/31/98 | 6/30/98 | 6/30/99 | |||
| Revenues | - | - | - | 4.262 | 5.870 | 2.045 | 3.945 |
| Income from Oper. | - | - | - | 0.077 | 0.707 | -0.025 | 0.660 |
| Net Income | - | - | - | -0.102 | 0.317 | -0.076 | 0.348 |
| E.P.S | - | - | - | -0.030 | 0.090 | -0.020 | 0.100 |
| Revenue Growth (%) | - | - | - | 37.744 | 92.86 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | 1.81 | 12.05 | 16.74 | - |
| Net Profit Margin (%) | - | - | - | - | 5.40 | 8.82 | - |
| Cash Flow - Oper. | 0.05 | - | - | ||||
| Cash Flow - Inv. | -0.12 | - | - | ||||
| Cash Flow - Fin. | -0.01 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/99 | Financial Ratios | ||||
| Total Assets | 2.45 | Current Assets | - | Current Ratio | - |
| Total Liab. | 3.05 | Current Liab. | - | Debt Ratio | 124.64% |
| Total Equity | -0.60 | Working Cap. | 0.58 | Debt to Equity Ratio | - |
| Cash | 0.45 | Return on Assets | 14.22% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay indebtedness, move to a larger facility, expand our marketing, add to our working capital, buy additional equipment and have funds for potential acquisitions. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Harris, Michael, P.A. |
| Bank's Law Firm | Wolin, Ridley & Miller LLP |
| Registrar/Transfer Agent | American Stock Transfer & Trust Co |
| Auditor | Kaufman, Rossin & Company |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |